Inactive Instrument

Bayer Aktiengesellschaft Share Price Other OTC

Equities

BAYRY

US0727303028

Pharmaceuticals

Financials

Sales 2024 * 47.12B 51.17B 4,027B Sales 2025 * 47.89B 52B 4,092B Capitalization 28.16B 30.58B 2,407B
Net income 2024 * 2.35B 2.55B 201B Net income 2025 * 3.18B 3.46B 272B EV / Sales 2024 * 1.29 x
Net Debt 2024 * 32.4B 35.18B 2,769B Net Debt 2025 * 30.17B 32.76B 2,578B EV / Sales 2025 * 1.22 x
P/E ratio 2024 *
12.5 x
P/E ratio 2025 *
8.78 x
Employees -
Yield 2024 *
0.38%
Yield 2025 *
0.78%
Free-Float 99.97%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 57 31/03/23
Director of Finance/CFO 55 25/04/18
Chief Tech/Sci/R&D Officer 55 31/03/20
Members of the board TitleAgeSince
Director/Board Member 68 31/03/17
Director/Board Member 67 31/03/21
Director/Board Member 67 31/03/02
More insiders
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Calendar
More about the company